FAQ: hyperCORE International's New President Appointment
Summary
hyperCORE International has appointed Nicholas Focil as its new president, bringing nearly two decades of clinical operations leadership to enhance the network's global impact in clinical research.
Who has been appointed as the new president of hyperCORE International?
Nicholas Focil has been appointed as the new president of hyperCORE International.
What experience does Nicholas Focil bring to hyperCORE International?
Nicholas Focil brings nearly two decades of experience in clinical operations leadership, strategic partnerships, and expansion into emerging markets, along with founding and leading FOMAT Medical Research.
What is hyperCORE International?
hyperCORE International is a partner site network of leading clinical research site organizations, founded in 2019, with over 80 active trial sites across five countries and two continents.
What are the goals of hyperCORE International under Nicholas Focil’s presidency?
Under Nicholas Focil’s presidency, hyperCORE International aims to enhance site capabilities, broaden the reach of its trials, and deliver more diverse, high-quality research benefiting both patients and sponsors.
Who was the outgoing president of hyperCORE International?
Carlos Orantes was the outgoing president of hyperCORE International.
What has been the contribution of Carlos Orantes to hyperCORE International?
Carlos Orantes laid a strong foundation that continues to guide hyperCORE’s growth and fostered a high-performing, inclusive network.
What is the significance of Nicholas Focil’s appointment for hyperCORE International?
Nicholas Focil’s appointment signifies an exciting milestone and evolution for hyperCORE International’s leadership to continue its path of excellence in clinical research.
How does hyperCORE International contribute to clinical research?
hyperCORE International advances clinical research through safe, ethical, timely studies; efficient enrollment; and superior retention, empowered by its members’ top-tier awards for performance, quality, and innovation.
Where is hyperCORE International headquartered?
hyperCORE International is headquartered in Lake Mary, FL, as indicated by the press release location.
What is the reach of hyperCORE International’s clinical trials?
hyperCORE International’s partners have jointly completed 7,000+ studies involving over 140,000 randomized participants across more than 70 therapeutic areas in the U.S. and Latin America.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at 24-7 Press Release
Article Control ID: 124483